KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Current Leases (2019 - 2023)

Vir Biotechnology's Current Leases history spans 2 years, with the latest figure at $240000.0 for Q1 2020.

  • For Q1 2020, Current Leases changed N/A year-over-year to $240000.0; the TTM value through Mar 2020 reached $240000.0, changed N/A, while the annual FY2019 figure was $237000.0, N/A changed from the prior year.
  • Current Leases for Q1 2020 was $240000.0 at Vir Biotechnology, up from $237000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $240000.0 in Q1 2020 and bottomed at $237000.0 in Q4 2019.